Ligand profile
CHEMBL1728587
Bioactivity hit from ChEMBL on a similar protein.
Bound to: KP13_01981 — Chaperone protein dnaK
Identifiers
Database identifiers and provenance.
- Ligand ID
CHEMBL1728587- UniProt (similar protein)
C3TRK2- Target protein
- KP13_01981
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 49.3
- −1 ≤ LogP ≤ 5 2.38
- MW ≤ 500 Da 233.3
- LogP ≤ 5 2.38
- H-bond donors ≤ 5 2
- H-bond acceptors ≤ 10 3
- Rotatable bonds ≤ 10 3
- TPSA ≤ 140 Ų 49.3
Matches PAINS filter: mannich_A(296). May be a frequent false positive in HTS — review carefully.
Chemical representations
Canonical representations for cheminformatics workflows.
O=C(NCc1ccccc1O)c1cccs1O=C(NCc1ccccc1O)c1cccs1
InChI=1S/C12H11NO2S/c14-10-5-2-1-4-9(10)8-13-12(15)11-6-3-7-16-11/h1-7,14H,8H2,(H,13,15)InChI=1S/C12H11NO2S/c14-10-5-2-1-4-9(10)8-13-12(15)11-6-3-7-16-11/h1-7,14H,8H2,(H,13,15)
WRHPXDCIHFLNLP-UHFFFAOYSA-NWRHPXDCIHFLNLP-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ sequence
- Source
- ChEMBL
- Activity
- Active
- Binding sites
- PF00012
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ChEMBL ChEMBL compound CHEMBL1728587 →
- UniProt UniProt C3TRK2 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “CHEMBL1728587”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_01981.
PDB 20
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 99
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).